Program

June 1–3, 2027 at the Hilton Tampa Downtown. The full program will be published once the program committee confirms it. Here is what to expect.

Session Formats

Symposia

Each symposium opens with a short talk on unmet needs, followed by invited talks on the state of the art and open discussion.

Oral presentations

Selected abstracts presented by clinicians, scientists and trainees, each followed by questions from the floor.

Panels & guidelines

Expert panels working through new and emerging international guidelines and how to use them.

Poster discussions

Posters are discussed during every break, so trainees and senior investigators meet face to face.

Sample Day

Based on the format of the 19th meeting. Times are indicative.

07:45WelcomeOpening and introduction
08:00PlenaryExpanding worldwide collaboration in rare endocrine tumors
08:40SymposiumPheochromocytoma & paraganglioma
10:10BreakCoffee and poster discussions
10:40SymposiumPituitary tumors
13:00BreakLunch and poster discussions
13:30OralsSelected abstract presentations
14:30SymposiumMEN2 syndrome
16:20PanelGuidelines for advanced medullary thyroid cancer
17:10SymposiumBilateral macronodular adrenal disease

Scientific Themes

The program covers the classic MEN syndromes and the wider family of rare and hereditary endocrine tumors, including thyroid, parathyroid, adrenal, pituitary and pancreatic tumors.

Submit an abstract

2027 theme

AI in healthcare

Machine learning for imaging, pathology and genomics, risk prediction, and what responsible AI means for rare-disease care.

MEN1

Multiple endocrine neoplasia type 1

MEN2

Multiple endocrine neoplasia type 2

MTC

Medullary thyroid cancer

PPGL

Pheochromocytoma & paraganglioma

Pituitary

Pituitary tumors

Parathyroid

Parathyroid disease

PanNETs

Pancreatic neuroendocrine tumors

BMAD

Bilateral macronodular adrenal disease

Genetics